2025 英卡思巴黎国际年会
大会日程

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

Objectives: The aim of this study was to verify the functional recovery of scar tissues. At the moment there is no unanimity on the therapeutic approach to be used and many are the proposals both invasive and non-invasive for the treatment of scars. In this study we have therefore evaluated the effects of a non-invasive method on scar tissue, in terms of reduction of fibrosis and improvement of sensitivity.

Introduction: Many factors influence the healing of a wound and an unaesthetic and dysfunctional scar evolution is placed in a framework of persistence of a state of inflammation in which the deposition of collagen disassembles the tissue and alters its appearance and function. The result is aesthetic by generation of a fibrous tissue, which does not follow the structure of the original tissue, and functional, due to the tissue retractions that cause pain and movement limitation. The fibrotic scar evolution is accompanied by sensitivity disorders in terms of hyperesthesia and hypoesthesia.

Materials / method: We studied patients with chronic scars, associated with the referenced centers for the VEMF THERAPY procedure, through an approach that included ultrasound assessments and sensitivity studies. The results were complemented with those obtained from a group of patients for which the histological evaluation was available.

Results: After the treatment with VEMF THERAPY, conducted weekly for an average of six sessions the tissues reported a clear softening of the scar tissue and patients reported an improvement in sensitivity in the treated areas.

Conclusion: At the moment, there are no univocal therapeutic proposals for the study of scars. The use of a procedure combining mechanical stimulation by vacuum and electromagnetic fields, such as VEMF THERAPY, has allowed to improve the morpho-functional characteristics of scar tissues.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： BIODERMOGENESI®

利益冲突声明

您有否接受任何资金来支持研究这个主题？
是
请注明名称（个人，公司，学会等等）: Dr Ian Strawford is a paid consultant to Dermalux Aesthetic Technology Ltd. As part of this consultancy, he is provided with Dermalux devices and compensated for testing these and providing expert clinical advice. The opinions expressed in this publication are solely those of the author and are not influenced by his consultancy relationship with Dermalux Aesthetic Technology Ltd

您是否接受过关于这项研究的任何酬金或其他报酬？
是
请注明名称（个人，公司，学会等等）: Dr Ian Strawford is a paid consultant to Dermalux Aesthetic Technology Ltd. As part of this consultancy, he is provided with Dermalux devices and compensated for testing these and providing expert clinical advice. The opinions expressed in this publication are solely those of the author and are not influenced by his consultancy relationship with Dermalux Aesthetic Technology Ltd

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作的完成感谢以下机构的支持： thanks to novacutan

Objectives: Being dedicated to medicine aesthetics industry for over 20 years, Singclean has effectively provided novel aesthetic solutions to global markets. At the same time, global regenerative aesthetic products(PLLA, PDRN, CaHA) market space will further expand, Singclean focus on it and newly launched a series of products.

Conclusion: Singclean conforms to the evolution of facial injection aesthetics, integrates theory and practices and provides innovative aesthetic solutions to consumers.

利益冲突声明

您有否接受任何资金来支持研究这个主题？
否

您是否接受过关于这项研究的任何酬金或其他报酬？
否

你是否和任何与您的研究所涉及的药物，材料或工具有密切联系的实体存在财务关系？
否

你是否拥有或者您已经为您此研究中的工具，药物或材料申请任何专利？
否

这项工作没有任何直接或间接的资金支持。由作者自己承担责任。